Maimonides medcial center
Brooklyn, New York, 11219, United States
NCT Number: NCT02126501
To compare the 2 methods of weaning of nasal continuous positive airway pressure (CPAP) in premature babies born between 26 and 32 weeks
Looking for future studies?
Notify Me26 week–32 week
All sexes
Interventional
Not applicable
Brooklyn, New York, 11219, United States
To study the weight and the post menstrual age (PMA) at the time of NCPAP wean utilizing the method of sudden wean as compared to gradual wean.
Methods: A prospective randomized trial was conducted comparing sudden weaning with gradual weaning from NCPAP in neonates with gestational age between 26 and 32 weeks. The patients were randomized to one of the two methods of weaning from NCPAP and their success was compared
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NCPAP will be removed by gradually decreasing pressure over 24 hours once the weaning is decided
Time frame: Completion of Nasal Continuous Positive Airway Pressure (NCPAP) treatment, expected average of 4 weeks
Time frame: when off supplemental oxygen expected average of 2 weeks
Time frame: Completion of Nasal Continuous Positive Airway Pressure (NCPAP) treatment, expected average of 4 weeks
Time frame: when ready to be discharged, expected average of 6-8 weeks
Maimonides Medical Center
Other
Randomized Control Trial of Weaning NCPAP From Preterm Infants: Sudden Wean Versus Weaning by Gradually Decreasing Pressure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05987800
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jette, Brussels Capital, Belgium
View Trial DetailsNCT04209946
Female Urogenital Diseases and Pregnancy Complications, Lung Diseases
Irvine, California, United States
View Trial DetailsNCT05036603
Atelectasis Neonatal, Bronchopulmonary Dysplasia
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT04295564
Female Urogenital Diseases and Pregnancy Complications, Lung Diseases
Portland, Oregon, United States
View Trial Details